Stay updated on Pembrolizumab in MPM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.

Latest updates to the Pembrolizumab in MPM Clinical Trial page
- Check7 days agoChange DetectedMinor site revision updated from v3.3.3 to v3.3.4; no changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's Locations section was updated to include additional geographic regions and site entries. The revision version was updated to v3.3.3.SummaryDifference1%

- Check50 days agoChange Detected- Page revision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded notes that publications are provided voluntarily by the study submitter and that some publication data are automatically pulled from PubMed, along with a system revision tag ('Revision: v3.3.1'). The previous wording stating that publications are automatically created by ClinicalTrials.gov from PubMed data, potentially about the study, was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check65 days agoChange DetectedThe government funding/operating status notification on the page has been removed. This change does not affect the study details, eligibility criteria, or contact information.SummaryDifference0.2%

- Check79 days agoChange DetectedNo significant content changes detected on the Study Details page. The sections including eligibility criteria, interventions, outcomes, and locations appear unchanged from the prior version.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.